Skip to content

Universal access to HIV treatment threatened by failure of will

Microbicides can work, CAPRISA trial shows, but more trials needed before approval

Adolescents living with HIV face complex psychosocial concerns: require targeted, comprehensive services

Lopinavir/ritonavir plus raltegravir NRTI-sparing regimen as effective as traditional HAART

Child mortality falls after mothers receive HIV drugs

Large-scale impact of ART on mortality in Brazil, South Africa: big successes but mind the gaps

Requiring tuberculin skin tests before implementing IPT leads to avoidable and substantial number of TB cases

HIV infections soar amongst Eastern European 'street youth'

Newer HIV drugs cost-effective for Africa